1. Home
  2. CTOR vs QNCX Comparison

CTOR vs QNCX Comparison

Compare CTOR & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • QNCX
  • Stock Information
  • Founded
  • CTOR 2021
  • QNCX 2012
  • Country
  • CTOR United States
  • QNCX United States
  • Employees
  • CTOR N/A
  • QNCX N/A
  • Industry
  • CTOR
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CTOR
  • QNCX Health Care
  • Exchange
  • CTOR NYSE
  • QNCX Nasdaq
  • Market Cap
  • CTOR 89.9M
  • QNCX 62.0M
  • IPO Year
  • CTOR N/A
  • QNCX 2019
  • Fundamental
  • Price
  • CTOR $1.24
  • QNCX $1.48
  • Analyst Decision
  • CTOR Strong Buy
  • QNCX Strong Buy
  • Analyst Count
  • CTOR 2
  • QNCX 4
  • Target Price
  • CTOR $4.50
  • QNCX $9.50
  • AVG Volume (30 Days)
  • CTOR 64.8K
  • QNCX 121.0K
  • Earning Date
  • CTOR 02-14-2025
  • QNCX 03-31-2025
  • Dividend Yield
  • CTOR N/A
  • QNCX N/A
  • EPS Growth
  • CTOR N/A
  • QNCX N/A
  • EPS
  • CTOR N/A
  • QNCX N/A
  • Revenue
  • CTOR N/A
  • QNCX N/A
  • Revenue This Year
  • CTOR N/A
  • QNCX N/A
  • Revenue Next Year
  • CTOR N/A
  • QNCX N/A
  • P/E Ratio
  • CTOR N/A
  • QNCX N/A
  • Revenue Growth
  • CTOR N/A
  • QNCX N/A
  • 52 Week Low
  • CTOR $0.85
  • QNCX $0.51
  • 52 Week High
  • CTOR $49.00
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • QNCX 37.41
  • Support Level
  • CTOR N/A
  • QNCX $1.38
  • Resistance Level
  • CTOR N/A
  • QNCX $1.49
  • Average True Range (ATR)
  • CTOR 0.00
  • QNCX 0.11
  • MACD
  • CTOR 0.00
  • QNCX -0.01
  • Stochastic Oscillator
  • CTOR 0.00
  • QNCX 12.50

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: